Microneedles for drug delivery: trends and progress

Drug Delivery

Volumn 23, Issue 7, 2016, Pages 2338-2354

  Cheung, Karmen ^a   Das, Diganta B ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Autoregressive integrated moving average; microneedle; time series analysis

Indexed keywords

DRUG ADMINISTRATION ROUTE; EQUIPMENT DESIGN; HOLLOW MICRONEEDLE; HUMAN; MECHANICS; MEDICAL RESEARCH; MICRONEEDLE; MICROTECHNOLOGY; PATENT; PRIORITY JOURNAL; PUBLICATION; REVIEW; SKIN ABSORPTION; SKIN FUNCTION; SKIN PERMEABILITY; SKIN SURFACE; SOLID MICRONEEDLE; TIME SERIES ANALYSIS; TRANSDERMAL DRUG DELIVERY SYSTEM; TREND STUDY; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; EPIDERMIS; METABOLISM; MICROINJECTION; NEEDLE; PROCEDURES; SKIN; TRENDS;

ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; EPIDERMIS; HUMANS; MICROINJECTIONS; NEEDLES; SKIN; SKIN ABSORPTION;

EID: 84991570916     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.986309     Document Type: Review

References (164)

1. G.Aggarwal, A.Garg, S.Dhawan. (2009). Transdermal drug delivery:evolving technologies and expanding opportunities. Indian J Pharm Educ Res 43:251–9
2. Z.Ahmad, E.Stride, M.Edirisinghe. (2009). Novel preparation of transdermal drug-delivery patches and functional wound healing materials. J Drug Target 17:724–9
3. K.M.Ainslie, T.A.Desai. (2008). Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab Chip 8:1864–78
4. Akiyoshi B. Biocompatible microneedle, manufacture thereof, and sheet having the microneedle. Kitakyushu-shi Patent JP 2011083387, 18 April 2012
5. S.M.Al-Saidan. (2004). Transdermal self-permeation enhancement of ibuprofen. J Control Release 100:199–209
6. A.Arora, M.R.Prausnitz, S.Mitragotri. (2008). Micro-scale devices for transdermal drug delivery. Int J Pharm 364:227–36
7. A.Backovic, D.Wolfram, B.Del-Frari,. (2007). Simultaneous analysis of multiple serum protiens adhering to the surface of medical grade polydimethylsiloxane elastomers. J Immunol Methods 328:118–27
8. A.K.Banga. (2009). Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv 6:343–54
9. S.H.Bariya, M.C.Gohel, T.A.Mehta, O.P.Sharma. (2011). Microneedles:an emerging transdermal drug delivery system. J Pharm Pharmacol 64:11–29
10. S.H.Bariya, M.C.Gohel, T.A.Mehta, O.P.Sharma. (2012). Microneedles:an emerging transdermal drug delivery system. J Pharm Pharmacol 64:11–29
11. B.Bediz, E.Korkmaz, R.Khilwani,. (2013). Dissolvable microneedle arrays for intradermal delivery of biologics:fabrication and application. Pharm Res 31:117–35
12. S.R.Behin, I.S.Punitha, F.Saju. (2013). Development of matrix dispersion transdermal therapeutic system containing glipizide. Der Pharmacia Lettre 5:278–86
13. H.A.Benson. (2005). Transdermal drug delivery:penetration enhancement techniques. Current drug delivery 2:23–33
14. H.A.E.Benson, S.Namjoshi. (2008). Proteins and peptides:strategies for delivery to and across the skin. J Pharm Sci 97:3591–610
15. A.Bohling, S.Bielfeldt, A.Himmelmann,. (2013). Comparison of the stratum corneum thickness measured in vivo with confocal Raman spectroscopy and confocal reflectance microscopy. Skin Res Technol 20:50–7
16. B.Boettcher, K.J.Stahlhofer, V.Mattle,. (2013). Ultrasonographic assessment of skin thickness in patients with PCOS – a case-control study. Gynecol Endocrinol 29:380–3
17. C.Bronger. (2014). Insulin pen needles and adherance. Aus J Pharm 95:68–71
18. Y.Cai, M.Xu, M.Yuan,. (2014). Developments in human growth hormone preparations:sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes. Int J Nanomed 9:3527–38
19. Cantor AS, Stockholm AJ. Transdermal adhesive patch assembly with removable microneedle array and method of using same. St Paul Patent WO 2013096026, 27 June 2013
20. S.Chandrasekhar, L.K.Iyer, J.P.Panchal,. (2013). Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications. Exp Opin Drug Deliv 10:1155–70
21. Chen X, Zhang W. Method and apparatus for delivery of bioactive molecules to cells. Hong Kong Patent US 20130171722, 4 July 2013
22. K.Cheung, T.Han, D.B.Das. (2014). Effect of force of microneedle insertion on the permeability of insulin in skin. J Diabetes Sci Technol 8:444–52
23. H.J.Choi, B.J.Bondy, D.G.Yoo,. (2013). Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. J Control Release 166:159–71
24. Chowdhury DFH. Microneedle transdermal delivery device. Loughborough Patent US 2010042050, 18 February 2010
25. L.Y.Chu, S.-O.Choi, M.R.Prausnitz. (2010). Fabrication of dissolving polymer microneedles for controlled. J Pharm Sci 99:4228–38
26. L.Y.Chu, M.R.Prausnitz. (2011). Separable arrowhead microneedles. J Control Release 149:242–9
27. Cork University Patent (2011). A microneedle device and method for the fabrication thereof. EP 2289843 (http://www.google.com/patents/EP2289843A1?cl=en)
28. A.B.Cua, K.P.Wilhelm, H.I.Maibach. (1990). Elastic properties of human skin:relation to age, sex, and anatomical region. Arch Dermatol Res 282:283–8
29. L.Daugimont, N.Baron, G.Vandermeulen,. (2010). Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. J Memb Biol 236:117–25
30. S.P.Davis, B.J.Landis, Z.H.Adams,. (2004). Insertion of microneedles into skin:measurement and prediction of insertion force and needle fracture force. J Biomech 37:1155–63
31. S.P.Davis, W.Martanto, M.G.Allen, M.R.Prausnitz. (2005). Hollow metal microneedles for insulin delivery to diabetic rats. Trans Biomed Eng 52:909–15
32. R.S.Desale, K.S.Wagh, A.M.Akarte,. (2012). Microneedle technology for advanced drug delivery:a review. Int J PharmTech Res 4:181–9
33. D.L.Dhamech, V.B.Rajendra, V.B.Rathi,. (2010). Physical approaches to penetration enhancement. Int J Health Res 3:57–70
34. R.F.Donnelly, K.Mooney, E.Caffarel-Salvador,. (2014). Microneedle-mediated minimally invasive patient monitoring. Ther Drug Monit 36:10–17
35. R.F.Donnelly, A.D.Woolfson. (2014). Patient safety and beyond:what should we expect from microneedle arrays in the transdermal delivery arena? Therapeutic Deliv 5:653–62
36. Eckhoff PA, Hyde RA, Ishikawa MY, et al. Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject. Bellevue Patent US 20110118560, US 20110118656, US 20110117150, US 20110118652, US 20110118696, US 20110118653, US 20110118697, US 20110118698, US 20110118652, US 20110118656, 19 May 2011
37. A.El-Laboudi, N.S.Oliver, A.Cass, D.Johnston. (2013). Use of microneedle array devices for continuous glucose monitoring:a review. Diabetes Technol Ther 15:101–15
38. C.Edens, M.L.Collins, J.Ayers,. (2013). Measles vaccination using a microneedle patch. Vaccine 31:3403–9
39. J.J.Escobar-Chávez, D.Bonilla-Martínez, M.A.Villegas-González,. (2011). Microneedles:a valuable physical enhancer to increase transdermal drug delivery. J Clin Pharmacol 51:964–77
40. E.Ezan. (2013). Pharmacokinetic studies of protein drugs:past, present and future. Adv Drug Deliv Rev 65:1065–73
41. J.Y.Fang, P.F.Liu, C.M.Huang. (2008). Decreasing systemic toxicity via transdermal delivery of anticancer drugs. Curr Drug Metab 9:592–7
42. M.Fazil, A.Ali, S.Baboota,. (2013). Exploring drug delivery systems for treating osteoporosis. Exp Opin Drug Deliv 10:1123–36
43. H.S.Gill, S.-M.Kang, F.-S.Quan, R.W.Compans. (2014). Cutaneous immunization:an evolving paradigm in influenza vaccines. Exp Opin Drug Deliv 11:615–27
44. T.Gratieri, I.Alberti, M.Lapteva, Y.N.Kalia. (2013). Next generation intra- and transdermal therapeutic systems:using non- and minimally-invasive technologies to increase drug delivery into and across the skin. Eur J Pharm Sci 50:609–22
45. M.J.Garland, E.Caffarel-Salvador, K.Migalska,. (2012). Dissolving polymeric microneedle arrays for electrically assisted transdermal. J Control Release 159:52–9
46. M.J.Garland, K.Migalska, T.Mazlelaa,. (2011). Microneedle arrays as medical devices for enhanced transdermal drug delivery. Exp Rev Med Devices 8:459–82
47. M.S.Giri Nandagopal, R.Antony, S.Rangabhashiyam, N.Sreekumar. (2014). Overview of microneedle system:a third generation transdermal drug delivery approach. Microsystem Technol 20:1249–72
48. S.D.Gittard, A.Ovsianikov, B.N.Chichkov,. (2010). Two-photon polymerization of microneedles for transdermal drug delivery. Expert Opin Drug Deliv 7:513–33
49. Gonzalez BA, Burton SA, Hu J, et al. Hollow microneedle arrays. St Paul Patent WO 2011014514, 3 February 2011
50. H.Gray. (2005). Gray’s anatomy, 39th ed. Spain:Elsevier
51. H.Gray. (2008). Gray’s anatomy. 40th ed. Spain:Elsevier Limited
52. P.Griss, G.Stemme. (2003). Side-opened out-of-plane microneedles for microfluidic transdermal liquid transfer. IEEE J Microelectromech Syst 12:296–301
53. J.Gupta, E.I.Felner, M.R.Prausnitz. (2009). Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther 11:329–37
54. R.H.Guy. (1996). Current status and future prospects of trandermal drug delivery. Pharm Res 13:1765–9
55. T.Han, D.B.Das. (2013). Permeability enhancement for transdermal delivery of large molecule using low-frequency sonophoresis combined with microneedles. J Pharm Sci 102:3614–22
56. S.Hashmi, P.Ling, G.Hashmi,. (1995). Genetic transformation of nematodes using arrays of micromechanical piercing structures. Biotechniques 19:766–70
57. S.Henry, D.V.McAllister, M.G.Allen, M.R.Prausnitz. (1998). Microfabricated microneedles:a novel approach to transdermal drug delivery. J Pharm Sci 87:922–5
58. A.Herwadkar, A.K.Banga. (2012). Peptide and protein transdermal drug delivery. Drug Discov Today Technol 9:147–54
59. J.Z.Hilt, N.A.Peppas. (2005). Microfabricated drug delivery devices. Int J Pharm 206:15–23
60. Honda K, Motoi M, Takada K. Method for producing stamper for microneedle. Kyoto Patent CA 2696810, JP 2011078618, WO 2011043086, AU 2010201434, KR 2011067009, EP 2343102 A1, 10 February 2011
61. X.Hong, L.Wei, F.Wu,. (2013). Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine. Drug Des Dev Ther 7:945–52
62. Huizhen Z, Huibin W, WZhang X, Eizheng J. Degradable polymer-based microneedle patch and its preparation method. Beijing Patent CN 102000020, 6 April 2011
63. K.B.Ita. (2014). Transdermal drug delivery:progress and challenges. J Drug Deliv Sci Technol 24:245–50
64. S.Indermun, R.Luttge, Y.E.Choonara,. (2014). Current advances in the fabrication of microneedles for transdermal delivery. J Control Release 185:130–8
65. Y.Ito, E.Hagiwara, A.Saeki,. (2006). Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 29:82–8
66. A.Jain, P.Jain, J.Kurmi,. (2014). Novel strategies for effective transdermal drug delivery:a review. Crit Rev Ther Drug Carrier Syst 31:219–72
67. D.Jain, V.Jain, R.Singh. (2011). Novel antigen delivery technologies:a review. Drug Deliv Transl Res 1:103–12
68. H.Kalluri, A.K.Banga. (2011). Transdermal delivery of proteins. Am Ass Pharm Sci 12:431–41
69. S.Kamboj, V.Jhawat, V.Saini, S.Bala. (2013). Recent advances in permeation enhancement techniques for transdermal drug delivery systems:a review. Curr Drug Ther 8:181–8
70. P.K.Karande, A.Jain, S.Mitragotri. (2006). Relationships between skin’s electrical impedance and permeability in the presence of chemical enhancers. J Control Release 110:307–13
71. H.Katsumi, Y.S.Quan, F.Kamiyam,. (2014). Development of a novel transdermal delivery system of peptide and protein drugs using microneedle arrays. Yakugaku Zasshi 134:63–7
72. H.Khan, P.Mehta, H.Msallam,. (2014). Smart microneedle coatings for controlled delivery and biomedical analysis. J Drug Target 22:790–5
73. P.Khanna, J.A.Strom, S.Bhansali. (2008). Microneedle-based automated therapy for diabetes mellitus. J Diabetes Sci Technol 2:1122–9
74. Kobayashi K, Hamamoto H. Applicator device of pinholder type microneedle. Kagawa Patent WO 2011016230, 10 February 2011
75. E.E.Kis, G.Winter, J.Myschik. (2012). Devices for intradermal vaccination. Vaccine 30:523–38
76. J.S.Kochhar, S.Zou, S.Y.Chan, L.Kang. (2012). Protein encapsulation in polymeric microneedles by photolithography. Int J Nanomed 7:3143–54
77. S.Kommareddy, B.C.Baudner, A.Bonificio,. (2013). Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine 31:3435–41
78. K.M.Krapp, J.L.Longe. (1998). How products are made. Detroit:Gale Research
79. D.G.Koutsonanos, R.W.Compans, L.Skountzou. (2013). Targeting the skin for microneedle delivery of influenza vaccine. Adv Exp Med Biol 785:121–32
80. L.Langkjær, J.Brange, G.M.Grodsky, R.H.Guy. (1998). Iontophoresis of monomeric insulin analogues in vitro:effects of insulin charge and skin pretreatment. J Control Release 51:47–56
81. S.S.Lanke, J.G.Strom, A.K.Banga. (2009). Enhancement of transdermal delivery of heparin by various physical and chemical enhancement techniques. Crit Rev Ther Drug Carrier Syst 26:581–606
82. G.Lawrence. (2002). The hypodermic syringe. Lancet 359:1074
83. J.W.Lee, M.R.Han, J.H.Park. (2013). Polymer microneedles for transdermal drug delivery. J Drug Target 21:211–23
84. K.Lee, H.Jung. (2012). Drawing lithography for microneedles:a review of fundamentals and biomedical applications. Biomaterials 33:7309–26
85. K.Lee, C.Y.Lee, H.Jung. (2011). Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose. Biomaterials 32:3134e3140
86. Y.Lee, K.Hwang. (2002). Skin thickness of Korean adults. Surg Radiol Anat 24:183–9
87. H.Li, Y.Yu, D.S.Faraji,. (2013). Novel engineered systems for oral, mucosal and transdermal drug delivery. J Drug Target 21:611–29
88. Li M, Liu Y, Wang C, et al. Inactivated vaccine for immunoprophylaxis of bovine mastitis caused by Escherichia coli and its preparation method. Raleigh Patent CN 101991846, 30 March 2011
89. N.Li, L.-H.Peng, X.Chen,. (2011b). Transcutaneous vaccines:novel advances in technology and delivery for overcoming the barriers. Vaccine 29:6179–90
90. Lim CY. The plastic microneedle strip. Singapore Patent WO 2013066262, 10 May 2013
91. H.Liebl, L.C.Kloth. (2012). Skin cell proliferation stimulated by microneedles. J Am Coll Clin Wound Spec 4:2–6
92. M.H.Ling, M.C.Chen. (2013). Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats. Acta Biomater 9:8952–61
93. N.Magnenat-Thalmann, P.Kalra, J.L.Lévêque,. (2002). A computational skin model:fold and wrinkle formation. IEEE Trans Inf Technol Biomed 6:317–23
94. I.Mansoor, Y.Liu, U.O.Häfeli, B.Stoeber. (2013). Arrays of hollow out-of-plane microneedles made by metal electrodeposition onto solvent cast conductive polymer structures. J Micromech Microeng 23:1–10
95. C.J.Martin, C.J.Allender, K.R.Brian,. (2012). Low temperature fabrication of Biodegradable sugar glass microneedles for transdermal drug delivery applications. J Control Release 158:93–101
96. W.Martanto, S.P.Davis, N.R.Holiday,. (2004). Transdermal delivery of insulin using microneedles in vivo. Pharm Res 21:947–52
97. L.Margetts, R.Sawyer. (2007). Transdermal drug delivery:principles and opioid therapy. Cont Educ Anaesth Crit Care Pain 7:171–6
98. H.S.McAllister, D.V.Allen, M.G.Allen, M.R.Prausnitz. (1998). Microfabricated microneedles:a novel approach to transdermal drug delivery. J Pharm Sci 87:922–5
99. M.Milewski, N.K.Brogden, A.L.Stinchcomb. (2010). Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opin Drug Deliv 7:617–29
100. M.Milewski, A.Mitra. (2012). Recent developments in microneedle technology for transdermal drug delivery & vaccination. Drug Dev Deliv 12:30–5
101. S.Mitragotri. (2012). Mechanical disruption of skin barrier for vaccine delivery. Drug Deliv Syst 27:202–12
102. S.Mitragotri. (2013). Devices for overcoming biological barriers:the use of physical forces to disrupt the barriers. Adv Drug Deliv Rev 65:100–3
103. S.Mitragotri, J.Kost. (2004). Low-frequency sonophoresis:a review. Adv Drug Deliv Rev 56:589–601
104. Moga BJ, Chase KB, Smith GD. DD device. Madison Patent WO 2011084951, US 20110172645, 14 July 2011
105. M.Nalesniak, K.Iwaniak, R.Kasperek, E.Poleszak. (2013). A review of TTS-development, types and preparations. Curr Issues Pharm Med Sci 26:88–93
106. H.S.Nalwa. (2014). A special issue on reviews in nanomedicine, drug delivery and vaccine development. J Biomed Nanotechnol 10:1635–40
107. R.J.Natayan. (2014). Transdermal delivery of insulin via microneedles. J Biomed Nanotechnol 10:2244–60
108. M.G.Nava-Arzaluz, L.Calderón-Lojero, D.Quintanar-Guerrero,. (2012). Microneedles as transdermal delivery systems:combination with other enhancing strategies. Curr Drug Deliv 9:57–73
109. A.Nayak, D.B.Das. (2013). Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine. Biotechnol Lett 35:1351–63
110. A.Nayak, D.B.Das, G.V.Vladisavljevic. (2014). Microneedle assisted permeation of lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel. Pharm Res 31:1170–84
111. Nayak A, Babla H, Han T, Das DB. (in press). Lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel delivery by combined microneedle and ultrasound. Drug Deliv. DOI:10.3109/10717544.2014.935985. [Epub ahead of print]
112. L.Nordquist, N.Roxhed, P.Griss, G.Stemm. (2007). Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control:an initial comparison with subcutaneous administration. Pharm Res 24:1381–8
113. J.J.Norman, J.M.Arya, M.A.McClain,. (2014). Microneedle patches:usability and acceptability for self-vaccination against influenza. Vaccine 32:1856–62
114. O.Olatunji, C.C.Igwe, A.S.Ahmed,. (2014). Microneedles from fish scale biopolymer. Appl Polym Sci 131:1–10
115. J.L.Osborne, I.C.Sanchez, D.R.Paul. (2013). An asymptotic analysis of drug delivery from transdermal patches. J Memb Sci 442:27–30
116. A.Pankratz. (1983). Forecasting with Univariate Box–Jenkins Models:concepts and cases. New York:John Wiley & Sons. ISBN:978-0-471-09023-6
117. J.H.Park, M.G.Allen, M.R.Prausnitz. (2005). Biodegradable polymer microneedles:fabrication, mechanics and transdermal drug delivery. J Control Release 104:51–66
118. J.S.Petrofsky, M.Prowse, E.Lohman. (2008). The influence of ageing and diabetes on skin and subcutaneous fat thickness in different regions of the body. J Appl Res 8:55–61
119. M.B.R.Pierre, F.C.Rossetti. (2014). Microneedle-based drug delivery systems for transdermal route. Curr Drug Targets 15:281–91
120. M.R.Prausnitz. (2004). Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581–7
121. M.R.Prausnitz, R.Langer. (2008). Transdermal drug delivery. Nat Biotechnol 26:1261–8
122. M.R.Prausnitz, J.A.Mikszta, M.Cormier, A.K.Andrianov. (2009). Microneedle-based vaccines. Curr Top Microbiol Immunol 333:369–93
123. M.R.Prausnitz, S.Mitragoti, R.Langer. (2004). Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3:115–24
124. S.Ravi, P.K.Sharma, M.Bansal. (2011). A review:transdermal drug delivery of nicotine. Int J Drug Dev Res 3:1–8
125. M.Rizwan, M.Aqil, S.Talegaonkar,. (2009). Enhanced transdermal drug delivery techniques:an extensive review of patents. Recent Pat Drug Deliv Formul 3:105–24
126. J.E.Rose, M.E.Jarvik, K.D.Rose. (1984). Transdermal administration of nicotine. Drug Alcohol Depend 13:209–13
127. N.Roxhed, T.C.Gasser, P.Griss,. (2007). Penetration-enhanced ultrasharp microneedles and prediction on skin interaction for efficient transdermal drug delivery. J Microelectromech Syst 16:1429–40
128. V.Sachdeva, A.K.Banga. (2011). Microneedles and their applications. Recent Pat Drug Deliv Formul 5:95–132
129. Saacs E, Cobbledick T. A microneedle roller. Borehamwood Patent GB2472778A, 23 February 2011
130. S.Seidenari, A.Pagnoni, A.Di Nardo, A.Giannetti. (1994). Echographic evaluation with image analysis of normal skin:variations according to age and sex. Skin Pharmacol 7:201–9
131. U.U.Shah, M.Roberts, M.O.Gul,. (2011). Needle-free and microneedle drug delivery in children:a case for disease-modifying antirheumatic drugs (DMARDs). Int J Pharm 416:1–11
132. M.Shikida. (2012). Fabrication of microneedles by MEMS technologies. Drug Deliv Syst 27:176–83
133. V.R.Sinha, M.P.Kaur. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26:1131–40
134. N.Singh, H.Kalluri, A.Herwadkar,. (2012). Transcending the skin barrier to deliver peptides and proteins using active technologies. Crit Rev Ther Drug Carrier Syst 29:265–98
135. N.D.Singh, A.K.Banga. (2013). Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles. J Drug Target 21:354–66
136. T.R.Singh, N.J.Dunne, E.Cunningham, R.F.Donnelly. (2011). Review of patents on micro needle applicators. Recent Pat Drug Deliv Formul 5:11–23
137. T.R.Singh, M.J.Garland, C.M.Cassidy,. (2010). Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul 4:1–17
138. L.K.Smalls, R.R.Wickett, M.O.Visscher. (2006). Effect of dermal thickness, tissue composition, and body site on skin biomechanical properties. Skin Res Technol 12:43–9
139. Stinchcomb AL, Banks SL, Golinski MJ, et al. Cannabidiol prodrugs in topical and transdermal administration with microneedles. Lexington Patent WO 2011026144, S 20110052694, 3 March 2011
140. R.K.Subedi, S.Y.Oh, M.-K.Chun, H.-K.Choi. (2010). Recent advances in transdermal drug delivery. Arch Pharm Res 33:339–51
141. Sugimura H, Suzuki G, Ueno M, et al. Microneedle and method of manufacturing microneedle. Tokyo Patent US 20130030374 A1, 31 January 2013
142. S.P.Sullivan, N.Murthy, M.R.Prausnitz. (2008). Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater 20:933–8
143. S.Swain, S.Beg, A.Singh,. (2011). Advanced techniques for penetration enhancement in transdermal drug delivery system. Curr Drug Deliv 8:456–73
144. T.Tanner, R.Marks. (2008). Delivering drugs by the transdermal route:review and comment. Skin Res Technol 14:249–60
145. M.J.Taylor, T.S.Sahota. (2013). New technologies in insulin delivery. Pract Diabetes 30:21–6
146. B.M.Torrisi, V.Zarnitsyn, M.R.Prausnitz,. (2013). Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A. J Control Release 165:146–52
147. H.Trommer, R.H.Neubert. (2006). Overcoming the stratum corneum:the modulation of skin penetration. A review. Skin Pharmacol Physiol 19:106–21
148. K.Tsioris, W.K.Raja, E.M.Pritchard,. (2012). Fabrication of silk microneedles for controlled-release drug delivery. Adv Functional Mater 22:330–5
149. T.M.Tuan-Mahmood, M.C.McCrudden, B.M.Torrisi,. (2013). Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci 50:623–37
150. D.Ukawala Ravikumar, J.Vasava. (2012). Physical enhancement techniques for transdermal delivery system:a review. Int J Pharm Technol 4:2174–200
151. K.van der Maaden, S.J.Trietsch, H.Kraan,. (2014). Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination:a study with polio vaccine in rats. Pharm Res 31:1845–54
152. Wang X, Chen X, Yu Z, Wang L. (2006). A novel fabrication approach for microneedles using silicon micromaching technology. 1st IEEE International Conference on Nano/Micro Engineered and Molecular Systems; Zhuhai
153. L.Wei-Ze, H.Mei-Rong, Z.Jian-Ping,. (2010). Super-short solid silicon microneedles for transdermal drug delivery applications. Int J Pharm 389:122–9
154. H.M.Wolff. (2014). Future of transdermal drug delivery systems (TDDS). Am Pharm Rev 17. http://www.americanpharmaceuticalreview.com/Featured-Articles/163672-Future-of-Transdermal-Drug-Delivery-Systems-TDDS/
155. F.Wu, S.Yang, W.Yuan, T.Jin. (2012). Challenges and strategies in developing microneedle patches for transdermal delivery of protein and peptide therapeutics. Curr Pharm Biotechnol 13:1292–8
156. J.D.Yadav, K.A.Vaidya, P.R.Kulkarni, R.Raut. (2011). Microneedles:promising technique for transdermal drug delivery. Int J Pharma Bio Sci 2:684–708
157. A.Yamashita, Y.Hirai, K.Tojo. (1996). Effect of ultrasound on rate of drug absorption through skin. J Chem Eng Japan 29:812–16
158. Y.Yang, H.Kalluri, A.K.Banga. (2011). Effects of chemical and physical enhancement techniques on transdermal delivery of cyanocobalamin (vitamin B12) in vitro. Pharmaceutics 3:474–84
159. Yue R, Wang Y. Metal microneedle array, transdermal patch, micro needle roller and micro needle electrode array. Beijing Patent CN 103263727, 28 August 2013
160. J.D.Zahn, Y.C.Hsieh, M.Yang. (2005). Components of an integrated microfluidic device for continuous glucose monitoring with responsive insulin delivery. Diabetes Technol Ther 7:536–45
161. Zhang D, Das DB, Rielly CD. (2014a). Potential of microneedle-assisted micro-particle delivery by gene guns:a review. Chem Eng Sci. DOI:10.1016/j.ces.2014.06.031 [Epub ahead of print]
162. Zhang D, Das DB, Rielly CD. (2014b). Microneedle assisted micro-particle delivery by gene guns:mathematical model formulation and experimental verification. Drug Deliv. DOI:10.3109/10717544.2013.864345 [Epub ahead of print]
163. J.Zhang, Q.Zhu, L.Zhang. (2013). Research advances in applications of microneedles in transdermal drug delivery. Pharma Care Res 13:326–31
164. Zhang L, Wu Z. Riamcinolone acetonide biodegradable maltose microneedle array for treating scar and its preparation method. Shanghai Patent CN 103181887, 3 July 2013